Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
KT-253, A Novel MDM2 Degrader and p53 Stabilizer, Has Sup... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
KT-253, A Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy Than MDM2 Small Molecule Inhibitors
0
Authors
Yogesh Chutake
21 more
Yogesh Chutake
•
Michele Mayo
19 more
•
Matthew Weiss
Published
December 9, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Cancer Therapeutics
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1158/1535-7163.mct-24-0306
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Cancer Therapeutics
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1158/1535-7163.mct-24-0306
License
CC-BY-NC-ND
